Magic mushroom compound tested to break opioid addiction
NCT ID NCT06796062
Summary
This study is testing whether a single dose of psilocybin, the active compound in 'magic mushrooms,' can help people with opioid addiction who are still using illicit drugs despite being on standard methadone treatment. It will involve 240 participants who will receive either a low, medium, or high dose of psilocybin in a controlled, supportive setting. The main goal is to see if the treatment safely helps people stay off illicit opioids for longer periods and reduces cravings.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIOID USE DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Duke City Recovery Toolbox
RECRUITINGAlbuquerque, New Mexico, 87102, United States
-
NYU Langone Health
RECRUITINGNew York, New York, 10016, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
StartCare
RECRUITINGBrooklyn, New York, 11206, United States
-
University of New Mexico
RECRUITINGAlbuquerque, New Mexico, 87106, United States
-
VIP Community Services, Inc
RECRUITINGThe Bronx, New York, 10457, United States
Conditions
Explore the condition pages connected to this study.